Skip to content

Urinary Catheter Self-Discontinuation After Urogynecology Surgery

Urinary Catheter Self-Discontinuation After Urogynecology Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05860634
Acronym
CATH
Enrollment
118
Registered
2023-05-16
Start date
2023-08-01
Completion date
2025-11-01
Last updated
2024-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter Related Complication, Pelvic Organ Prolapse, Stress Urinary Incontinence, Urinary Retention

Keywords

Post-operative urinary retention, Pelvic organ prolapse, Stress urinary incontinence, Cather self-discontinuation

Brief summary

The goal of this randomized clinical trial is to determine if removal of transurethral urinary catheters by patients at home is as safe as catheter removal in the office following urogynecologic surgery. Participants will be randomized to either standard catheter removal in the office or catheter self-removal at home.

Detailed description

This is a prospective, randomized, two-parallel arm, non-inferiority trial to evaluate two methods of catheter discontinuation in women with post-operative urinary retention (POUR) after surgery for pelvic organ prolapse (POP) or stress urinary incontinence (SUI). This study will evaluate whether self-discontinuation of transurethral catheter by patients is non-inferior to standard office discontinuation based on rates of persistent POUR on post-operative day (POD) 1.

Interventions

PROCEDURECatheter self-discontinuation

Self-discontinuation of a transurethral catheter

Sponsors

University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Are at least 18 years of age 2. Are fluent and able to read in English or Spanish 3. Undergo POP and/or SUI surgery (uterosacral ligament suspension, sacrospinous ligament fixation, sacral colpopexy, anterior colporrhaphy, posterior colporrhaphy, and/or mid-urethral sling) that occurs on Monday - Thursday 4. Have transurethral catheter in place at the conclusion of surgery as part of standard care 5. Are diagnosed with POUR on POD0 based on ultrasound bladder scan PVR of 100 mL or more 6. Are discharged home on the same day of surgery (POD 0)

Exclusion criteria

1. Have preoperative voiding dysfunction requiring self-catheterization or indwelling transurethral catheter 2. Have physical or mental impairment that would impact their ability to remove their catheter themselves. 3. Undergo urethral bulking injections as part of surgery 4. Have undergone a planned or unplanned urinary tract procedure requiring prolonged catheterization as standard of care (e.g. cystotomy repair, ureteral reimplantation, vesicovaginal fistula repair, urethral diverticulum repair)

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Postoperative Urinary RetentionPost-operative day 1Non-inferiority comparison of the rates of persistent POUR on POD1 between catheter self-discontinuation and standard office catheter. Persistent POUR is defined as PVR greater than 100 mL by bladder scan on POD1.

Secondary

MeasureTime frameDescription
Rates of postoperative urinary tract infection (UTI)within 6 weeks of surgeryRates of postoperative UTI within 6 weeks of surgery - UTI will be defined as treatment with antibiotics for symptoms of UTI.
Incidence of recurrent POURwithin 6 weeks of surgeryRecurrent POUR will be defined as any participant with successful POD1 voiding trial who later requires replacement of catheter due to recurrent POUR within 6 weeks of surgery. Recurrent POUR is defined as PVR greater than 100 mL by bladder scan after passing initial POD1 voiding trial.
Number of postoperative patient encounterswithin 6 weeks of surgeryNumber of postoperative patient encounters, including any patient call to the office, electronic medical record message to office from patient, office visit, or emergency department visit.
Patient satisfaction assessment via the Acceptability of Intervention Measure (AIM) QuestionnairePost-operative day 1Patient satisfaction with catheter removal method as assessed via the Acceptability of Intervention Measure (AIM) Questionnaire. The AIM Questionnaire is a 4-item questionnaire on a 5-point Likert scale. Response Scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree Scoring Instructions: Scale is created by averaging responses. Scale values range from 1 to 5. The higher the score is, the higher the degree the patient finds the intervention acceptable.
Patient satisfaction assessment via the the Surgical Satisfaction Questionnaire - 8 (SSQ-8).Post-operative day 1Patient satisfaction with catheter removal method as assessed via the Surgical Satisfaction Questionnaire - 8 (SSQ-8). The SSQ-8 is an 8-item questionnaire, with responses recorded on a 5-point Likert scale with responses from 0 Very Unsatisfied to 4 Very Satisfied. Scoring uses the mean average of the 8 scores being multiplied by 25 (the questionnaire is considered incomplete if more than 2 items are not answered), yielding a potential range of scores from 0 to 100. The higher the score is, the greater the degree of surgical satisfaction.

Countries

United States

Contacts

Primary ContactMary M Rieger, MD
mary.rieger@austin.utexas.edu512-324-8670

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026